7th IPF Summit

Welcome to the 7th IPF Summit, where we gather to explore the forefront of scientific advancements in the field of idiopathic pulmonary fibrosis (IPF). This comprehensive, three-day conference brings together experts and innovators from around the world to harness emerging biological understanding and employ novel dynamic preclinical models, all with the aim of advancing the next generation of IPF drugs.

With patents for Nintedanib and Pirfenidone set to expire in the next 3-6 years, the race is on to develop and introduce new therapies that surpass the current standard of care. Exciting developments are underway, such as Pliant Therapeutics' progression into phase 2b, readouts expected from FibroGen's phase 3 trial, Galecto's phase 2 study, and ongoing clinical trials by Bristol Myers Squibb and Boehringer Ingelheim. These efforts signify a pivotal moment in the pursuit of disease-modifying IPF drugs, with the potential to slow, halt, reverse, and regenerate progressively fibrosing lung tissue.

At the forefront of this transformative era, we recognize the increasing understanding of lung pathobiology and cell cross talk through multi-omic approaches. These approaches broaden the horizons of therapeutic targets and pave the way for groundbreaking interventions. Furthermore, the integration of imaging and artificial intelligence (AI) is becoming more prevalent, enabling the visualization of therapeutic efficacy beyond lung function. With cutting-edge AI algorithms and imaging techniques, researchers can capture imaging endpoints that provide valuable insights into treatment outcomes.

The 7th IPF Summit is your gateway to the latest advancements and unpublished data in the field of pulmonary fibrosis. During this comprehensive event, you and your team will have the opportunity to engage in in-depth discussions, gain new insights, and network with over 180 influential individuals shaping the future of IPF research and development. By attending this summit, you will be at the forefront of the IPF community, ensuring that you stay ahead of the curve and bring innovative ideas back to your therapeutic development efforts.

Join us at the 7th IPF Summit, where scientific excellence meets collaborative synergy, and together, we pave the way towards a brighter future for IPF patients worldwide.